These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35755213)

  • 1. Shorter Intensive Care Unit Stay (12 Hours) Post Thrombolysis Is Safe and Reduces Length of Stay for Minor Stroke Patients.
    Cencer S; Tubergen T; Packard L; Gritters D; LaCroix H; Frye A; Wills N; Zachariah J; Wees N; Khan N; Min J; Dejesus M; Combs J; Khan M
    Neurohospitalist; 2022 Jul; 12(3):504-507. PubMed ID: 35755213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.
    Yeo LL; Paliwal P; Teoh HL; Seet RC; Chan BP; Wakerley B; Liang S; Rathakrishnan R; Chong VF; Ting EY; Sharma VK
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e590-6. PubMed ID: 23954601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shorter Intensive Care Unit Stays? The Majority of Post-Intravenous tPA (Tissue-Type Plasminogen Activator) Symptomatic Hemorrhages Occur Within 12 Hours of Treatment.
    Chang A; Llinas EJ; Chen K; Llinas RH; Marsh EB
    Stroke; 2018 Jun; 49(6):1521-1524. PubMed ID: 29686025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.
    Hacke W; Albers G; Al-Rawi Y; Bogousslavsky J; Davalos A; Eliasziw M; Fischer M; Furlan A; Kaste M; Lees KR; Soehngen M; Warach S;
    Stroke; 2005 Jan; 36(1):66-73. PubMed ID: 15569863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC; Rabinstein AA
    Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Taking Warfarin with Subtherapeutic INR.
    Mowla A; Memon A; Razavi SM; Lail NS; Vaughn CB; Mohammadi P; Sawyer RN; Shirani P
    J Stroke Cerebrovasc Dis; 2021 May; 30(5):105678. PubMed ID: 33640783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of acute ischemic stroke due to tandem occlusion: should endovascular recanalization of the extracranial or intracranial occlusive lesion be done first?
    Rangel-Castilla L; Rajah GB; Shakir HJ; Shallwani H; Gandhi S; Davies JM; Snyder KV; Levy EI; Siddiqui AH
    Neurosurg Focus; 2017 Apr; 42(4):E16. PubMed ID: 28366065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CLOTBUST: design of a randomized trial of ultrasound-enhanced thrombolysis for acute ischemic stroke.
    Alexandrov AV; Wojner AW; Grotta JC;
    J Neuroimaging; 2004 Apr; 14(2):108-12. PubMed ID: 15095554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of intravenous thrombolysis with recombinant tissue type plasminogen activator (rt-PA) in different time windows on acute cerebral infarction patients with atrial fibrillation].
    Guo Y; Zhang CH; Wang HY; Lin YN; Wang Y; Sun XP
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(26):2054-8. PubMed ID: 27468616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.
    Khatri P; Kleindorfer DO; Devlin T; Sawyer RN; Starr M; Mejilla J; Broderick J; Chatterjee A; Jauch EC; Levine SR; Romano JG; Saver JL; Vagal A; Purdon B; Devenport J; Pavlov A; Yeatts SD;
    JAMA; 2018 Jul; 320(2):156-166. PubMed ID: 29998337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IV tPA is associated with increase in rates of intracerebral hemorrhage and length of stay in patients with acute stroke treated with endovascular treatment within 4.5 hours: should we bypass IV tPA in large vessel occlusion?
    Hassan AE; Ringheanu VM; Preston L; Tekle W; Qureshi AI
    J Neurointerv Surg; 2021 Feb; 13(2):114-118. PubMed ID: 32620575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Four-Year Experience of Symptomatic Intracranial Hemorrhage Following Intravenous Tissue Plasminogen Activator at a Comprehensive Stroke Center.
    Orlando A; Wagner JC; Fanale CV; Whaley M; McCarthy KL; Bar-Or D
    J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):969-76. PubMed ID: 26856464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials.
    Ramakrishnan TCR; Kumaravelu S; Narayan SK; Buddha SS; Murali C; Majeed PHA; Meenakshi-Sundaram S; Wadia RS; Sharma V; Basu I; Vijaya P; Salam KA; Barmare S; Vaid Z; Nirmal Raj KK; Wattamwar PR; Asokan K; Dhonge V; Nellikunja S; Namjoshi D; Srinivasa R; Laddhad DS; Deshpande SD; Raghunath B; Kalita J; Kumar M; Misra UK; Pradeep M;
    Am J Cardiovasc Drugs; 2018 Oct; 18(5):387-395. PubMed ID: 29948822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Mechanical Thrombectomy Without vs With Intravenous Thrombolysis on Functional Outcome Among Patients With Acute Ischemic Stroke: The SKIP Randomized Clinical Trial.
    Suzuki K; Matsumaru Y; Takeuchi M; Morimoto M; Kanazawa R; Takayama Y; Kamiya Y; Shigeta K; Okubo S; Hayakawa M; Ishii N; Koguchi Y; Takigawa T; Inoue M; Naito H; Ota T; Hirano T; Kato N; Ueda T; Iguchi Y; Akaji K; Tsuruta W; Miki K; Fujimoto S; Higashida T; Iwasaki M; Aoki J; Nishiyama Y; Otsuka T; Kimura K;
    JAMA; 2021 Jan; 325(3):244-253. PubMed ID: 33464334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
    Ahmed N; Kellert L; Lees KR; Mikulik R; Tatlisumak T; Toni D;
    JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models.
    Nisar T; Hanumanthu R; Khandelwal P
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104360. PubMed ID: 31501036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes After Endovascular Thrombectomy With or Without Alteplase in Routine Clinical Practice.
    Smith EE; Zerna C; Solomon N; Matsouaka R; Mac Grory B; Saver JL; Hill MD; Fonarow GC; Schwamm LH; Messé SR; Xian Y
    JAMA Neurol; 2022 Aug; 79(8):768-776. PubMed ID: 35696198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous thrombolysis in Chinese patients with mild acute ischemic stroke.
    Xiong Y; Yan R; Gu H; Wang S; Fisher M; Zhao X; Yang X; Wang C; Qi Z; Meng X; Li Z; Wang Y
    Ann Transl Med; 2021 May; 9(9):767. PubMed ID: 34268380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic respiratory and functional rehabilitation protocol for intensive care unit patients affected by COVID-19: a structured summary of a study protocol for a randomised controlled trial.
    Carvalho AC; Moreira J; Cubelo P; Cantista P; Branco CA; Guimarães B
    Trials; 2021 Apr; 22(1):268. PubMed ID: 33845878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.